Showing results 6 to 7 of 7
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Safety and antiviral activity of VIR-2218, an X-targeting RNAi therapeutic, in participants with chronic hepatitis B infection: week 48 follow-up results Proceeding/Conference:Journal of Hepatology | 2021 | ||
2018 |